University of Alabama at Birmingham at BioTechX Europe 2026

Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website

University of Alabama at Birmingham takes part in 6 sessions at BioTechX Europe 2026 in Basel. Its sessions span AI models trained on biological data, multi-omics research and real-world evidence for rare diseases. Distinctive topics include digital twins, virtual models of individual patients, and applying large biological AI models to speed up clinical trials.

OrganizationBioTechX Europe 2026 Attendance
Talk
Tue Oct 6
12:25
Applications of biological foundation models to accelerate clinical trials
AI in Clinical Trials
Talk
Tue Oct 6
12:25
Programmable medicine with digital twins
Bioinformatics + InSilico R&D
Chair
Tue Oct 6
15:25
Chair's remarks
Bioinformatics + InSilico R&D
Panel
Tue Oct 6
17:25
From Data to Diagnosis: The Power of Multi-Omics in Clinical Research
Bioinformatics + InSilico R&D · with CSEM, University of Vienna, Molecular Partners
Panel
Wed Oct 7
16:30
Importance of real-world evidence for rare diseases
Real World Data and Evidence · with UCB, Novartis, IPQ Analytics +1 more
Panel
Wed Oct 7
17:25
Your LLM is Monolingual – Your BioTech Company Isn’t. Now What?
What goes wrong when biotech teams working in many languages use AI models trained mostly on English, and what they can do.
with University of Zurich, Bayer

Explore the full BioTechX Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full BioTechX Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Alabama at Birmingham

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction